Want to see TSE:MLCO full AI Analyst Report?
Top Page
Mountain Valley MD
(MLCO)
Select Model
Select Model
Rating:43Neutral
Price Target:
C$0.05
▼(-33.75% Downside)
Action:Reiterated
Date:09/24/26
The score is held down primarily by weak financial performance—very small revenue scale alongside heavy operating losses and continued negative free cash flow (cash burn), plus equity volatility. Technical indicators are also soft (negative MACD and price below key short/mid-term moving averages), offering limited near-term support. Valuation provides little offset due to a negative P/E and no dividend yield data.
Positive Factors
Revenue growth
Reported revenue growth indicates that the company is expanding from its current base, providing evidence of some product or commercial traction. If maintained, this growth could improve operating leverage over time, although the very small revenue scale means the benefit is not yet substantial.
Negative Factors
Persistent cash burn
Ongoing operating and free cash flow losses show that the business is not self-funding and that reported losses are translating into substantial cash outflows. Continued burn can constrain investment capacity and increase reliance on future financing while the company seeks to scale revenue.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue growth
Reported revenue growth indicates that the company is expanding from its current base, providing evidence of some product or commercial traction. If maintained, this growth could improve operating leverage over time, although the very small revenue scale means the benefit is not yet substantial.
Read all positive factors
Mountain Valley MD (MLCO) vs. iShares MSCI Canada ETF (EWC)
Market Cap
C$25.14M
Dividend YieldN/A
Average Volume (3M)99.06K
Price to Earnings (P/E)―
Beta (1Y)-0.82
Revenue Growth48.94%
EPS Growth53.81%
CountryCA
Employees1
SectorHealthcare
Sector Strength45
IndustryBiotechnology
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding457,002,000
10 Day Avg. Volume121,249
30 Day Avg. Volume99,060
Financial Highlights & Ratios
PEG Ratio0.16
Price to Book (P/B)-199.92
Price to Sales (P/S)433.67
P/FCF Ratio-13.33
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Mountain Valley MD Business Overview & Revenue Model
Company Description
The More Life Co. Corp. is a biotechnology company, which engages in the provision of solutions to optimize human, animal, and plant health. Its patented technologies includes Quicksome™ and Quicksol™. The Quicksome™ patented technology utilizes p...
Mountain Valley MD Financial Statement Overview
Summary
Income Statement
18
Very Negative
Balance Sheet
38
Negative
Cash Flow
16
Very Negative
| Breakdown | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 65.00K | 49.00K | 60.00K | 0.00 | 110.00K |
| Gross Profit | -2.00K | 49.00K | -346.00K | -446.00K | 70.00K |
| EBITDA | -2.27M | -3.16M | -2.78M | -6.89M | -9.29M |
| Net Income | -2.79M | -7.47M | -7.67M | -7.44M | -9.71M |
Balance Sheet | |||||
| Total Assets | 524.00K | 2.74M | 8.97M | 16.77M | 25.27M |
| Cash, Cash Equivalents and Short-Term Investments | 334.00K | 1.72M | 5.92M | 9.71M | 14.22M |
| Total Debt | 403.00K | 0.00 | 0.00 | 6.00K | 44.00K |
| Total Liabilities | 665.00K | 209.00K | 258.00K | 591.00K | 422.00K |
| Stockholders Equity | -141.00K | 2.53M | 8.71M | 16.18M | 24.85M |
Cash Flow | |||||
| Free Cash Flow | -2.12M | -3.91M | -3.80M | -4.85M | -5.68M |
| Operating Cash Flow | -2.11M | -3.90M | -3.30M | -4.79M | -5.59M |
| Investing Cash Flow | 200.00K | -290.00K | -503.00K | 1.89M | -98.00K |
| Financing Cash Flow | 519.00K | 0.00 | -6.00K | -1.60M | 395.00K |
Mountain Valley MD Technical Analysis
Positive
0.08
Price Trends
0.07
Negative
0.07
Negative
0.05
Positive
Market Momentum
>-0.01
Negative
46.52
Neutral
26.67
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:MLCO, the sentiment is Positive. The current price of 0.08 is above the 20-day moving average (MA) of 0.06, above the 50-day MA of 0.07, and above the 200-day MA of 0.05, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 46.52 is Neutral, neither overbought nor oversold. The STOCH value of 26.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:MLCO.
Mountain Valley MD Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
45 Neutral | C$10.46M | -1.04 | 288.66% | ― | ― | -162.50% | |
43 Neutral | C$25.14M | -6.19 | -443.11% | ― | 48.94% | 53.81% | |
43 Neutral | C$16.95M | -2.67 | -338.76% | ― | ― | 31.00% | |
41 Neutral | C$9.34M | -2.94 | 28.59% | ― | 0.90% | 57.73% | |
37 Underperform | C$2.07M | -1.65 | -19.04% | ― | -12.84% | -681.25% |
* Healthcare Sector Average
TSE:MLCO
Mountain Valley MD
0.06
0.05
300.00%
TSE:RVV
Revive Therapeutics
0.03
<0.01
25.00%
TSE:PCLO
PharmaCielo
0.06
0.01
22.22%
TSE:CANB
CanadaBis Capital
0.02
-0.03
-62.50%
TSE:LOBE
Lobe Sciences
0.06
<0.01
10.00%
Mountain Valley MD Corporate Events
Business Operations and StrategyDelistings and Listing Changes
The More Life Company Updates U.S. and Canadian Trading Symbols After Rebrand
Positive
Aug 21, 2026
The More Life Company Corp., formerly Mountain Valley MD Holdings Inc., operates in the life sciences sector with a focus on technologies that enhance crop productivity and resilience and improve the formulation, stability and delivery of active i...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.